Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
|Nosocomial Infection Bacteremia Sepsis Pneumonia Urinary Tract Infection Clostridium Infection||Drug: 2% chlorhexidine gluconate impregnated cloth||Phase 1|
|Study Design:||Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
|Official Title:||Skin Cleansing With Chlorhexidine to Improve Nosocomial Infection Risks. (SCCIN Project)|
- Clinical: Primary blood stream infections and culture negative sepsis
- Microbiologic: Skin colonization from environment and endotracheal secretions
- Clinical: Laboratory confirmed blood stream infections
- Nosocomial infections
|Study Start Date:||June 2005|
|Study Completion Date:||July 2006|
Patients admitted to the medical intensive care unit at John H Stroger Hospital are randomly assigned to Unit A or B. Unit B was randomly selected as the intervention unit. For 6 months, all patients in Unit B will be bathed with the 2% CHG Antiseptic Cloth system and all patients in Unit A will receive soap and water baths. After this 6 month period, there will be a 2 to 4 week washout period and the interventions will cross over, with Unit A receiving Chlorhexidine baths and unit B receiving soap and water for 6 months.
Each week, two randomly selected patients will have cultures of the inguinal area, neck/subclavian region, and endotracheal aspirates. A comparison of the colonization of the skin and sputum will be done between the two intervention groups.
Daily infection surveillance will be done on all patients in the intensive care unit. A comparison of blood stream infections, clinical sepsis, and other nosocomial infections will be done between the two intervention groups.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00130221
|United States, Illinois|
|John H. Stroger Hospital of Cook County|
|Chicago, Illinois, United States, 60612|
|Principal Investigator:||Robert A Weinstein, MD||John H. Stroger Hospital of Cook County|